Key Details
Price
$8.42Last Dividend
$0.25Annual ROE
0.17%Beta
0.34Events Calendar
Next earnings date:
Mar 11, 2025Recent quarterly earnings:
Nov 12, 2024Recent annual earnings:
Mar 11, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Sept 16, 2024Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Monroe Capital (NASDAQ:MRCC ) Q3 2024 Earnings Call Transcript November 13, 2024 11:00 AM ET Company Participants Ted Koenig - CEO Mick Solimene - CFO and CIO Alex Parmacek - Deputy Portfolio Manager Conference Call Participants Christopher Nolan - Ladenburg Thalmann Robert Dodd - Raymond James Operator Welcome to Monroe Capital Corporation's Third Quarter 2024 Earnings Conference Call. Before we begin, I would like to take a moment to remind our listeners that remarks made during this call today may contain certain forward-looking statements, including statements regarding our goals, strategies, beliefs, future potential, operating results and cash flows, although we believe these statements are reasonable based on management's estimates, assumptions and projections as of today, November 13, 2024.
Monroe Capital (MRCC) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.25 per share a year ago.
CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC (“Monroe”) today announced the closing of its inaugural collateralized fund obligation (“CFO”) known as Monroe Capital CFO I, Ltd. The $315 million CFO provides investors access to a diversified portfolio of Monroe's strategies, including Monroe's flagship senior secured direct lending and alternative credit solutions platforms, in both rated and non-rated securities. Seth Friedman, Head of Structured Solutions for Monroe said, “We are thrilled to cl.
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings to three classes of notes issued by Monroe Capital Income Plus ABS Funding II, LLC (“MCIP II”), a securitization backed by a portfolio of recurring revenue and middle market corporate loans. Monroe Capital Income Plus ABS Funding II, LLC is a $255.0 million securitization managed by Monroe BDC Advisors, LLC (“Monroe” or the “Collateral Manager”), an affiliate of Monroe Capital LLC. The securitization consists of $163.2 million of Class.
CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC (“Monroe”) has been selected by Inc. Magazine's 2024 List of Founder-Friendly Investors. The list honors Lenders, Venture Capital and Private Equity firms with a track record of backing founder-led companies and helping them achieve success. As a founder-led business itself, Monroe understands that the key to success lies in supporting visionary leaders and their organization. The firm's investment strategy includes providing a partnership for founde.
CHICAGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Monroe Capital Corporation (the “Company”) (NASDAQ: MRCC) announced today that it will report its third quarter ended September 30, 2024 financial results on Tuesday, November 12, 2024, after the close of the financial markets.
CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC (“Monroe”) announced it acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the growth of Izzio Artisan Bakery. Founded in 1994 and based in Louisville, CO, Izzio Artisan Bakery is a family-owned wholesale bakery that produces traditional sourdough breads. The customer base primarily consists of U.S. grocery store chains. Izzio Artisan Bakery is recognized by end consumers and store purchasers fo.
Monroe Capital (MRCC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC (“Monroe”) announced it acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the acquisition of the Level Ex Games (“Level Ex”) pharma and life sciences division by Relevate Health Group (“Relevate”), an existing portfolio company of Mountaingate Capital. Based in Chicago, IL, Level Ex is a video game technology platform that delivers healthcare professional engagement solutions primarily for phar.
Monroe Capital (MRCC) has recently managed to outperform the broader BDC market, partly due to some additional certainty on the dividend coverage front after the Q2 report. However, if we dig deeper into the data, we will see that these improvements are temporary and the underlying picture remains uncertain. MRCC faces high leverage, dividend coverage issues, and deteriorating portfolio quality, making it risky for long-term investment despite a discount to NAV.
FAQ
- What is the primary business of Monroe Capital?
- What is the ticker symbol for Monroe Capital?
- Does Monroe Capital pay dividends?
- What sector is Monroe Capital in?
- What industry is Monroe Capital in?
- What country is Monroe Capital based in?
- When did Monroe Capital go public?
- Is Monroe Capital in the S&P 500?
- Is Monroe Capital in the NASDAQ 100?
- Is Monroe Capital in the Dow Jones?
- When was Monroe Capital's last earnings report?
- When does Monroe Capital report earnings?
- Should I buy Monroe Capital stock now?